These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19445446)

  • 81. Cranial prophylactic irradiation in locally advanced non-small cell lung carcinoma: current status and future perspectives.
    Topkan E; Yildirim BA; Selek U; Yavuz MN
    Oncology; 2009; 76(3):220-8. PubMed ID: 19218826
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [S-1 activity in non-small cell lung cancer in clinical practice].
    Inagaki M; Onuki T; Iguchi K; Ogata T; Hayashi Y; Saito K; Wakai Y; Takabe K; Shinohara Y; Suzuki K; Ohtani T; Horikoshi K
    Gan To Kagaku Ryoho; 2009 May; 36(5):763-7. PubMed ID: 19461174
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Efficacy and safety of iodine-125 radioactive seeds brachytherapy for advanced non-small cell lung cancer-A meta-analysis.
    Zhang W; Li J; Li R; Zhang Y; Han M; Ma W
    Brachytherapy; 2018; 17(2):439-448. PubMed ID: 29275079
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Recurrent metastatic pericarditis treated by chemotherapy].
    Attia S; Boussofara L; El Fekih L; Fenniche S; Belhabib D; Hassene H; Megdiche ML
    Tunis Med; 2008 Nov; 86(11):1027-8. PubMed ID: 19213507
    [No Abstract]   [Full Text] [Related]  

  • 85. Duration of chemotherapy for metastatic non-small-cell lung cancer: more may be not better.
    Sasse AD; Lima JP; Sasse EC; Santos LV
    J Clin Oncol; 2009 Dec; 27(35):e253; author reply e254. PubMed ID: 19884522
    [No Abstract]   [Full Text] [Related]  

  • 86. Intrabronchial brachytherapy using 226-radium source.
    Kolek V; Zajíc J; Srámek V; Klaclová T; Pridal I; Cwiertka K
    Acta Univ Palacki Olomuc Fac Med; 1993; 136():23-4. PubMed ID: 7887194
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Chemotherapy for lung cancer: the state of the art in 2009.
    Higgins MJ; Ettinger DS
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1365-78. PubMed ID: 19827996
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Interstitial high-dose-rate-brachytherapy in advanced esthesioneuroblastoma.
    Tselis N; Heyd R; Baghi M; Zamboglou N
    Laryngoscope; 2008 Nov; 118(11):2006-10. PubMed ID: 18641524
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival.
    Narayan K; van Dyk S; Bernshaw D; Rajasooriyar C; Kondalsamy-Chennakesavan S
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1529-35. PubMed ID: 19473780
    [TBL] [Abstract][Full Text] [Related]  

  • 90. VEGF in patients with non-small cell lung cancer during combination chemotherapy of carboplatin and paclitaxel.
    Shingyoji M; Ando S; Nishimura H; Nakajima T; Ishikawa A; Itakura M; Iizasa T; Kimura H
    Anticancer Res; 2009 Jul; 29(7):2635-9. PubMed ID: 19596939
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Advanced lung cancer: progress in individualized therapy].
    Bischoff A
    MMW Fortschr Med; 2009 May; 151(21):20. PubMed ID: 19537631
    [No Abstract]   [Full Text] [Related]  

  • 92. [The interstitial radiotherapy of lung cancer using enclosed 125I radiation sources].
    Anikin VA; Zubov OG
    Med Radiol (Mosk); 1990 Nov; 35(11):39-41. PubMed ID: 2259282
    [No Abstract]   [Full Text] [Related]  

  • 93. [Combination chemotherapy for treatment of metastasing non-small-cell lung carcinoma. Monotherapy of combinations of two or three agents--a survey of a Cochrane review].
    Mellemgaard A; Pappot H
    Ugeskr Laeger; 2009 Jun; 171(25):2084-7. PubMed ID: 19671386
    [No Abstract]   [Full Text] [Related]  

  • 94. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Elective nodal irradiation (ENI) in locally advanced non-small-cell lung cancer (NSCLC): evidence versus opinion?
    Belderbos JS; Kepka L; Kong FM; Martel MK; Videtic GM; Jeremic B
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):322; author reply 322-3. PubMed ID: 19362253
    [No Abstract]   [Full Text] [Related]  

  • 97. Induction chemotherapy before chemoradiation in locally advanced non-small-cell lung cancer: failure after failure, again and again.
    Jeremic B; Koning C
    J Clin Oncol; 2008 Apr; 26(10):e1-2. PubMed ID: 18375883
    [No Abstract]   [Full Text] [Related]  

  • 98. Locally advanced non-small cell lung cancer: the "local" issue.
    Movsas B
    Curr Probl Cancer; 1996; 20(3):197-212. PubMed ID: 8866210
    [No Abstract]   [Full Text] [Related]  

  • 99. [Circadian chemoradiotherapy of solid tumors].
    Svinarenko AV; Sukhina EN; Moskalenko IP; Nikiforova NA; Sorochan PP; Nasonova AN
    Vopr Onkol; 2010; 56(2):138-43. PubMed ID: 20552887
    [No Abstract]   [Full Text] [Related]  

  • 100. Targeted therapies in non-small-cell lung cancer: a paradigm in evolution.
    Sangha R; Lara PN; Mack P; Gandara DR
    Clin Lung Cancer; 2008; 9 Suppl 3():S90-1. PubMed ID: 19419929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.